5-Nitrosalicylaldehyde is a yellow crystalline solid that is synthesized through the nitration of salicylaldehyde. It acts as a versatile building block in organic synthesis, serving as a precursor for various heterocyclic compounds. Its reactivity stems from the presence of both aldehyde and nitro groups, allowing for a wide range of chemical transformations. 5-Nitrosalicylaldehyde is a crucial starting material in the synthesis of pharmaceuticals and agrochemicals. Its unique structural features make it a subject of interest in fields like medicinal chemistry, where its potential as a scaffold for drug development is explored. Additionally, its photophysical properties have attracted attention in the study of potential applications in materials science.'
| ID Source | ID |
|---|---|
| PubMed CID | 66808 |
| CHEMBL ID | 3660344 |
| SCHEMBL ID | 79298 |
| MeSH ID | M0064609 |
| Synonym |
|---|
| nsc-97387 |
| EN300-18390 |
| BB 0245783 |
| 2-hydroxy-5-nitro-benzaldehyde |
| OPREA1_813586 |
| AH-034/32841024 |
| nsc 881 |
| ai3-52608 |
| einecs 202-587-0 |
| nsc881 |
| 5-nitrosalicylaldehyde |
| 97-51-8 |
| benzaldehyde, 2-hydroxy-5-nitro- |
| 2-hydroxy-5-nitrobenzaldehyde |
| nsc-881 |
| salicylaldehyde, 5-nitro- |
| 2-hydroxy-5-nitrobenzaldehyde, 98% |
| STK346021 |
| AKOS000108208 |
| N0255 |
| BBL000323 |
| unii-zj6ggt3k66 |
| zj6ggt3k66 , |
| 2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde |
| 5-nitrososalicylaldehyde |
| PS-6254 |
| FT-0620721 |
| CS-M1907 |
| SCHEMBL79298 |
| us8614253, .3-39 |
| bdbm111008 |
| 2-hydroxy 5-nitrobenzaldehyde |
| DTXSID6059154 |
| 5-nitro salicylaldehyde |
| 5-nitro-2-hydroxy-benzaldehyde |
| 5-nitro-2-hydroxybenzaldehyde |
| Q-200288 |
| CHEMBL3660344 |
| mfcd00007337 |
| F2191-0160 |
| AC-3345 |
| GEO-01539 |
| SY004427 |
| AMY31519 |
| F11283 |
| 6-hydroxy-3-nitrobenzaldehyde |
| 2-formyl-4-nitrophenol |
| Z57160172 |
| PD129677 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (31.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||